Skip to main content

letter

. 1995 Feb;71(832):125. doi: 10.1136/pgmj.71.832.125

Heterochromatin heteromorphism and variation in apolipoprotein A phenotype--a pilot study.

J Franzen, B W Johansson, A Gustafson

PMCID: PMC2397935 PMID: 7724433

125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Breslow J. L. Human apolipoprotein molecular biology and genetic variation. Annu Rev Biochem. 1985;54:699–727. doi: 10.1146/annurev.bi.54.070185.003411. [DOI] [PubMed] [Google Scholar]
Franzén J., Johansson B. W., Gustafson A. Reduced high density lipoproteins as a risk factor after acute myocardial infarction. Acta Med Scand. 1987;221(4):357–362. doi: 10.1111/j.0954-6820.1987.tb03356.x. [DOI] [PubMed] [Google Scholar]
Pero R. W., Bryngelsson C., Bryngelsson T., Lindholm L., Scherstén B., Trell E., Janzon L., Franzén J., Johansson B. W. The effects of smoking, hypertension and cardiovascular disease on the estimation of unscheduled DNA synthesis and covalent binding to DNA induced by N-acetoxy-2-acetylaminofluorene in resting human mononuclear leukocytes. Atherosclerosis. 1983 Aug;48(2):119–129. doi: 10.1016/0021-9150(83)90098-9. [DOI] [PubMed] [Google Scholar]
Scanu A. M., Lagocki P., Chung J. Effect of apolipoprotein A-II on the structure of high-density lipoproteins: relationship to the activity of lecithin:cholesterol acyl transferase in vitro. Ann N Y Acad Sci. 1980;348:160–173. doi: 10.1111/j.1749-6632.1980.tb21298.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES